The FCF Yield 5yr Average is calculated by taking the five year average free cash flow of a company, and dividing it by the current enterprise value. Enterprise Value is calculated by taking the market capitalization plus debt, minority interest and preferred shares, minus total cash and cash equivalents. The average FCF of a company is determined by looking at the cash generated by operations of the company. The Free Cash Flow Yield 5 Year Average of Puma Biotechnology, Inc. (NasdaqGS:PBYI) is -0.078797.
When the stock portfolio is diversified, there is a good chance that some stocks will be winners and some will be losers. Regularly reviewing portfolio performance can help the investor stay the course. Keeping track of performance can help spot stocks that might no longer be beneficial to the goals of the investor. There may be times after a review where nothing needs to be adjusted, but staying ahead of the curve can put the individual in a good place when the investing waters become choppy.
The Price Index is a ratio that indicates the return of a share price over a past period. The price index of Puma Biotechnology, Inc. (NasdaqGS:PBYI) for last month was 1.45023. This is calculated by taking the current share price and dividing by the share price one month ago. If the ratio is greater than 1, then that means there has been an increase in price over the month. If the ratio is less than 1, then we can determine that there has been a decrease in price. Similarly, investors look up the share price over 12 month periods. The Price Index 12m for Puma Biotechnology, Inc. (NasdaqGS:PBYI) is 0.47211.
Price Range 52 Weeks
Some of the best financial predictions are formed by using a variety of financial tools. The Price Range 52 Weeks is one of the tools that investors use to determine the lowest and highest price at which a stock has traded in the previous 52 weeks. The Price Range of Puma Biotechnology, Inc. (NasdaqGS:PBYI) over the past 52 weeks is 0.473000. The 52-week range can be found in the stock’s quote summary.
The Current Ratio of Puma Biotechnology, Inc. (NasdaqGS:PBYI) is 3.02. The Current Ratio is used by investors to determine whether a company can pay short term and long term debts. The current ratio looks at all the liquid and non-liquid assets compared to the company’s total current liabilities. A high current ratio indicates that the company might have trouble managing their working capital. A low current ratio (when the current liabilities are higher than the current assets) indicates that the company may have trouble paying their short term obligations.
The Piotroski F-Score is a scoring system between 1-9 that determines a firm’s financial strength. The score helps determine if a company’s stock is valuable or not. The Piotroski F-Score of Puma Biotechnology, Inc. (NasdaqGS:PBYI) is 5. A score of nine indicates a high value stock, while a score of one indicates a low value stock. The score is calculated by the return on assets (ROA), Cash flow return on assets (CFROA), change in return of assets, and quality of earnings. It is also calculated by a change in gearing or leverage, liquidity, and change in shares in issue. The score is also determined by change in gross margin and change in asset turnover.
C Score (Montier)
The C-Score is a system developed by James Montier that helps determine whether a company is involved in falsifying their financial statements. The C-Score is calculated by a variety of items, including a growing difference in net income verse cash flow, increasing days outstanding, growing days sales of inventory, increasing assets to sales, declines in depreciation, and high total asset growth. The C-Score of Puma Biotechnology, Inc. (NasdaqGS:PBYI) is 1.00000. The score ranges on a scale of -1 to 6. If the score is -1, then there is not enough information to determine the C-Score. If the number is at zero (0) then there is no evidence of fraudulent book cooking, whereas a number of 6 indicates a high likelihood of fraudulent activity. The C-Score assists investors in assessing the likelihood of a company cheating in the books.
The MF Rank (aka the Magic Formula) is a formula that pinpoints a valuable company trading at a good price. The formula is calculated by looking at companies that have a high earnings yield as well as a high return on invested capital. The MF Rank of Puma Biotechnology, Inc. (NasdaqGS:PBYI) is 15340. A company with a low rank is considered a good company to invest in. The Magic Formula was introduced in a book written by Joel Greenblatt, entitled, “The Little Book that Beats the Market”.
The Value Composite One (VC1) is a method that investors use to determine a company’s value. The VC1 of Puma Biotechnology, Inc. (NasdaqGS:PBYI) is 87. A company with a value of 0 is thought to be an undervalued company, while a company with a value of 100 is considered an overvalued company. The VC1 is calculated using the price to book value, price to sales, EBITDA to EV, price to cash flow, and price to earnings. Similarly, the Value Composite Two (VC2) is calculated with the same ratios, but adds the Shareholder Yield. The Value Composite Two of Puma Biotechnology, Inc. (NasdaqGS:PBYI) is 86.
Stock volatility is a percentage that indicates whether a stock is a desirable purchase. Investors look at the Volatility 12m to determine if a company has a low volatility percentage or not over the course of a year. The Volatility 12m of Puma Biotechnology, Inc. (NasdaqGS:PBYI) is 92.912900. This is calculated by taking weekly log normal returns and standard deviation of the share price over one year annualized. The lower the number, a company is thought to have low volatility. The Volatility 3m is a similar percentage determined by the daily log normal returns and standard deviation of the share price over 3 months. The Volatility 3m of Puma Biotechnology, Inc. (NasdaqGS:PBYI) is 90.588200. The Volatility 6m is the same, except measured over the course of six months. The Volatility 6m is 118.996500.
Ever wonder how investors predict positive share price momentum? The Cross SMA 50/200, also known as the “Golden Cross” is the fifty day moving average divided by the two hundred day moving average. The SMA 50/200 for Puma Biotechnology, Inc. (NasdaqGS:PBYI) is currently 0.74100. If the Golden Cross is greater than 1, then the 50 day moving average is above the 200 day moving average – indicating a positive share price momentum. If the Golden Cross is less than 1, then the 50 day moving average is below the 200 day moving average, indicating that the price might drop.
As we move closer to the end of the year, investors might be closely monitoring key economic reports. Staying on top of the most recent reports can help the individual see the overall landscape a bit clearer. It may be overwhelming to keep up with every single report that comes out, but knowing which information has a bigger impact on stock investments may help the investor. Investors may already be trying to gauge how they will set themselves up for success over the next couple of quarters. They may be still going over all the latest company earnings reports trying to identify some names that can give the portfolio a boost as we move into the New Year.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.